PIQUR Therapeutics AG was founded in 2011 as a spin-off of the University of Basel with a focus on the development of novel drugs based on the inhibition of the PI3K/mTOR pathway, which is deregulated in many cancers and several other diseases.


Hochbergerstrasse 60C, 4057 Basel, Switzerland

Facts & figures
  • Type of organization

    Private company

  • Year of foundation


  • Number of employees in Switzerland


Key business